Patent · US Active

Antisense antibacterial method and compound

US7625873B2 · kind B2 · utility

27Cited by
15References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2006
Grant dateDec 1, 2009
Priority date
Expiry dateAug 24, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3233
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50° to 60° C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.